These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

763 related articles for article (PubMed ID: 25788409)

  • 1. Dedicator of cytokinesis 2, a novel regulator for smooth muscle phenotypic modulation and vascular remodeling.
    Guo X; Shi N; Cui XB; Wang JN; Fukui Y; Chen SY
    Circ Res; 2015 May; 116(10):e71-80. PubMed ID: 25788409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactomedin 2 Regulates Smooth Muscle Phenotypic Modulation and Vascular Remodeling Through Mediating Runt-Related Transcription Factor 2 Binding to Serum Response Factor.
    Shi N; Li CX; Cui XB; Tomarev SI; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):446-454. PubMed ID: 28062493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant Protein A, a Novel Regulator for Smooth Muscle Phenotypic Modulation and Vascular Remodeling-Brief Report.
    Ran R; Cai D; King SD; Que X; Bath JM; Chen SY
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):808-814. PubMed ID: 33267655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
    Wang YC; Cui XB; Chuang YH; Chen SY
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor 12 Is a Novel Regulator of Vascular Smooth Muscle Cell Plasticity and Fate.
    Song SH; Kim K; Jo EK; Kim YW; Kwon JS; Bae SS; Sung JH; Park SG; Kim JT; Suh W
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1928-36. PubMed ID: 27470512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
    Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic Factor With G Patch and FHA Domains 1 Is a Novel Regulator of Vascular Injury.
    Zhou B; Zeng S; Li N; Yu L; Yang G; Yang Y; Zhang X; Fang M; Xia J; Xu Y
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):675-684. PubMed ID: 28153879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardin regulates vascular response to injury through miR-24/-29a and platelet-derived growth factor receptor-β.
    Talasila A; Yu H; Ackers-Johnson M; Bot M; van Berkel T; Bennett MR; Bot I; Sinha S
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2355-65. PubMed ID: 23825366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.
    Halterman JA; Kwon HM; Zargham R; Bortz PD; Wamhoff BR
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2287-96. PubMed ID: 21757659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
    Huang C; Zhang W; Zhu Y
    Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epac1 Deficiency Attenuated Vascular Smooth Muscle Cell Migration and Neointimal Formation.
    Kato Y; Yokoyama U; Yanai C; Ishige R; Kurotaki D; Umemura M; Fujita T; Kubota T; Okumura S; Sata M; Tamura T; Ishikawa Y
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2617-25. PubMed ID: 26427796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
    Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
    Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
    Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermedin reduces neointima formation by regulating vascular smooth muscle cell phenotype via cAMP/PKA pathway.
    Zhu Q; Ni XQ; Lu WW; Zhang JS; Ren JL; Wu D; Chen Y; Zhang LS; Yu YR; Tang CS; Qi YF
    Atherosclerosis; 2017 Nov; 266():212-222. PubMed ID: 29053988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
    Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
    Cheng Y; Liu X; Yang J; Lin Y; Xu DZ; Lu Q; Deitch EA; Huo Y; Delphin ES; Zhang C
    Circ Res; 2009 Jul; 105(2):158-66. PubMed ID: 19542014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
    Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
    Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Smooth Muscle Tenascin-X Inhibits Vascular Remodeling Through Increased TGF-β Signaling.
    Liang G; Lv XF; Huang W; Jin YJ; Roquid KA; Kawase H; Offermanns S
    Arterioscler Thromb Vasc Biol; 2024 Aug; 44(8):1748-1763. PubMed ID: 38934115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.